Risankizumab improved health-related quality of life, fatigue, pain and work productivity in psoriatic arthritis: results of KEEPsAKE 1.

MLA

Kristensen, Lars Erik, et al. “Risankizumab Improved Health-Related Quality of Life, Fatigue, Pain and Work Productivity in Psoriatic Arthritis: Results of KEEPsAKE 1.” Rheumatology, vol. 62, no. 2, Feb. 2023, pp. 629–37. EBSCOhost, https://doi.org/10.1093/rheumatology/keac342.

APA

Kristensen, L. E., Soliman, A. M., Papp, K., White, D., Barcomb, L., Lu, W., Eldred, A., & Behrens, F. (2023). Risankizumab improved health-related quality of life, fatigue, pain and work productivity in psoriatic arthritis: results of KEEPsAKE 1. Rheumatology, 62(2), 629–637. https://doi.org/10.1093/rheumatology/keac342

Chicago

Kristensen, Lars Erik, Ahmed M Soliman, Kim Papp, Douglas White, Lisa Barcomb, Wenjing Lu, Ann Eldred, and Frank Behrens. 2023. “Risankizumab Improved Health-Related Quality of Life, Fatigue, Pain and Work Productivity in Psoriatic Arthritis: Results of KEEPsAKE 1.” Rheumatology 62 (2): 629–37. doi:10.1093/rheumatology/keac342.